A Follow-Up Study of Straight and Tapered Dental Implants in the Front Upper Jaw
A Prospective Clinical Follow-up Study of Straight and Tapered Dental Implants Placed in the Anterior Maxilla
1 other identifier
interventional
51
1 country
1
Brief Summary
This prospective study aims to evaluate 5-year clinical, radiographic, and patient-reported outcomes of implant-supported crowns and bridges placed on Neoss implants (ProActive Straight and Tapered) in the anterior maxilla (region 13 - 23). The study is conducted at Brånemarkkliniken, Public Dental Service, Västra Götalandsregionen, Sweden. While the treatment involves established methods and CE-marked devices, long-term data for this specific indication are limited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 21, 2021
CompletedFirst Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2030
April 22, 2026
April 1, 2026
9 years
April 16, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Implant Survival
Absence of implant loss during the study period.
Baseline, 1 year, and 5 years
Change in marginal bone level around implants
Change in marginal bone level around implants as assessed by radiographic evaluation using standardized, anonymized radiographs. Measurements will be performed by an independent examiner.
Baseline, 1 year, and 5 years
Secondary Outcomes (4)
Peri-implant Soft Tissue Status and change
Baseline, 1 year, and 5 years
Individual Tooth-Related Pink Esthetic Score (PES)
Baseline, 1 year, and 5 years
Patient-Reported Outcomes
Baseline, 1 year, and 5 years
Incidence of Adverse Events
Throughout the 5-year study period
Study Arms (1)
Implant-Supported Crowns and Bridges on Neoss Implants (ProActive Straight and Tapered)
EXPERIMENTALParticipants will receive implant-supported crowns or bridges supported by Neoss implants (ProActive Straight and Tapered) placed in the anterior maxilla as part of routine clinical treatment. Prosthetic rehabilitation will be performed following standard clinical procedures, and participants will be followed for 5 years to assess clinical, radiographic, and patient-reported outcomes.
Interventions
Participants will receive implant-supported crowns or bridges supported by Neoss dental implants (ProActive Straight and Tapered) placed in the anterior maxilla. Implant placement and prosthetic rehabilitation will be performed according to standard clinical procedures using a commercially available CE-marked implant system. The implants serve as support for fixed prosthetic restorations, and participants will be followed for 5 years to evaluate clinical, radiographic, and patient-reported outcomes.
Eligibility Criteria
You may qualify if:
- Signed informed consent to participate in the study. Adults ≥18 years of age requiring an implant-supported crown or bridge in the anterior maxilla (region 13-23).
- No prior bone augmentation required at the implant site. The implant site must be free from signs of infection.
You may not qualify if:
- Individuals under 18 years of age. Individuals unable to provide informed consent due to disease, mental disorder, impaired health status, or similar conditions.
- Presence of systemic or local disease/condition contraindicating implant treatment.
- Lack of availability for follow-up visits over the 5-year study period. Previous radiotherapy to the head, neck, or jaw region. Untreated or uncontrolled periodontitis and/or peri-implantitis. Use of immunosuppressive medication. Uncontrolled diabetes mellitus. Severe alcohol and/or substance abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Branemarkklinikenlead
- Neoss Ltd., Harrogate, UKcollaborator
Study Sites (1)
Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden
Gothenburg, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Victoria F Stenport, DDS, PhD
Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden
- STUDY CHAIR
Jan Kowar, DDS, PhD
Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2026
First Posted
April 22, 2026
Study Start
March 21, 2021
Primary Completion (Estimated)
March 31, 2030
Study Completion (Estimated)
July 31, 2030
Last Updated
April 22, 2026
Record last verified: 2026-04